Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Akira Kinugasa"'
Autor:
Motoki Sato, Toru Inagaki, Hiroyuki Eto, Masaki Kato, Katsuya Hirata, Futoshi Nishiwaki, Akira Kinugasa
Publikováno v:
ECS Transactions. 25:257-266
The Kansai Electric Power Co., Inc. (KEPCO) and Mitsubishi Materials Corporation (MMC) have been jointly developing disk-type intermediate temperature solid oxide fuel cells (IT-SOFC) with lanthanum gallate-based electrolyte, since FY 2001. As of FY2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fc8d3f67705c558069225a7a54e3e25
https://doi.org/10.1149/1.3205533
https://doi.org/10.1149/1.3205533
Autor:
Daisuke Ueno, Futoshi Nishiwaki, Masaki Kato, Katsuya Hirata, Toru Inagaki, Akira Kinugasa, Naoya Murakami, Hiroyuki Eto
Publikováno v:
The Proceedings of the International Conference on Power Engineering (ICOPE). :2-197
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a4f268b2ac220e1a04b171a4ec96d25
https://doi.org/10.1299/jsmeicope.2009.2._2-197_
https://doi.org/10.1299/jsmeicope.2009.2._2-197_
Autor:
Akira Kinugasa, Hiromasa Kamimoto, Takashi Miyoshi, Miki Fujimoto, Masaaki Wada, Koji Sawada, Takashi Shimoyama
Publikováno v:
Journal of Interferon & Cytokine Research. 19:85-88
Twenty chronic hepatitis C patients with baseline levels of thyroid hormones, antithyroglobulin, and antimicrosomal antibodies within the normal range were monitored by thyroid testing during a 26-week treatment with interferon-alpha2a (IFN-alpha2a).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5086f373e43424f89303f2245ae69f8f
https://doi.org/10.1089/107999099314450
https://doi.org/10.1089/107999099314450
Autor:
Koji Sawada, Shigeyuki Shintani, Takashi Nishigami, Kyong Boo Kang, Akira Kinugasa, Masaaki Wada, Takashi Shimoyama
Publikováno v:
Internal Medicine. 36:248-254
The serum autoantibodies, antinuclear antibody, anti-DNA antibody, anti-smooth muscle antibody, antithyroglobulin antibody, antimicrosomal antibody, antimitochondrial antibody, rheumatoid factor and antibody to deoxyribonucleoprotein were measured at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc0508fbddc7e42b7e68263ffa69d3c9
https://doi.org/10.2169/internalmedicine.36.248
https://doi.org/10.2169/internalmedicine.36.248
Autor:
Takashi Shimoyama, Keiji Nakasho, Akira Kinugasa, Kunio Uematsu, Shigeyuki Shintani, Masaaki Wada, Takashi Nishigami, Koji Sawada
Publikováno v:
Kanzo. 37:572-579
C型肝炎ウイルス(HCV)感染を伴う散発性晩発性皮膚ポルフィリン症の1男性例を報告する.本例は48歳男性で,輸血歴および多飲酒歴を有していた.入院時血液検査でHCV抗体,HCV RNAが陽性を示す
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70213a2e74bf0e25bf31acd8d27a11d2
https://doi.org/10.2957/kanzo.37.572
https://doi.org/10.2957/kanzo.37.572
Autor:
Shigeyuki Shintani, Wataru Hiraizumi, Koji Sawada, Takashi Shimoyama, Mitsuko Suehiro, Masaaki Wada, Minoru Fukuchi, Miki Fujimoto, Akira Kinugasa
Publikováno v:
Internal Medicine. 34:1097-1100
The present report describes a patient who developed Graves' disease 3 months after inception of retreatment with higher doses of interferon-α2a for chronic hepatitis C, although the initial 6-month treatment caused no serious adverse reactions. Sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b5b72c07c4b2893fe12cb3b0bf2289d
https://doi.org/10.2169/internalmedicine.34.1097
https://doi.org/10.2169/internalmedicine.34.1097